The METS-IR is Independently Related to Bone Mineral Density, FRAX Score, and Bone Fracture Among U.S. Non-diabetic Adults: a Cross-sectional Study Based on NHANES
Overview
Physiology
Authors
Affiliations
Aim: The purpose of this study was to investigate the association between the metabolic score for insulin resistance (METS-IR) and bone mineral density (BMD) in American non-diabetic adults.
Methods: We conducted a cross-sectional study with 1114 non-diabetic adults from the National Health and Nutrition Examination Survey cycle (2013-2014). The associations between METS-IR and BMD of total femur and spine were assessed by the multiple linear regression and verified the non-linear relationship with a smooth curve fit and threshold effect model. Furthermore, we evaluated the relationship between METS-IR, FRAX score, and history of bone fractures.
Results: We found that BMD of the total femur and spine increased by 0.005 g/cm and 0.005 g/cm, respectively, for a one-unit increase of METS-IR in all participants. This positive association was more pronounced among higher METS-IR participants, and there was a non-linear relationship, which was more significant when the MTTS-IR was < 41.62 or the METS-IR was < 41.39 (β = 0.008, β = 0.011, all P < 0.05). We also found that METS-IR was positively correlated with both FRAX scores in all female participants. However, METS-IR was positively correlated only with the 10-year hip fracture risk score in male participants with fractures. No significant association between METS-IR and a history of bone fractures.
Conclusions: In American non-diabetic adults, there is a correlation between elevated levels of METS-IR within the lower range and increased BMD as well as decreased risk of fractures, suggesting that METS-IR holds promise as a novel biomarker for guiding osteoporosis (OP) prevention. However, it is important to carefully balance the potential benefits and risks of METS-IR in OP.
Insulin Resistance and Bone Mineral Density: A Comprehensive Examination Using UK Biobank Data.
Hung Y, Yu T, Alizargar J Healthcare (Basel). 2025; 12(24.
PMID: 39765929 PMC: 11727659. DOI: 10.3390/healthcare12242502.
Shirinezhad A, Azarboo A, Ghaseminejad-Raeini A, Kanaani Nejad F, Zareshahi N, Amiri S Front Endocrinol (Lausanne). 2025; 15:1499479.
PMID: 39744182 PMC: 11688183. DOI: 10.3389/fendo.2024.1499479.
Potassium Intake and Bone Health: A Narrative Review.
Abate V, Vergatti A, Altavilla N, Garofano F, Salcuni A, Rendina D Nutrients. 2024; 16(17).
PMID: 39275337 PMC: 11397259. DOI: 10.3390/nu16173016.
Tan M, Zhu S, Wang G, Liu Z Sci Rep. 2024; 14(1):7005.
PMID: 38523143 PMC: 10961310. DOI: 10.1038/s41598-024-57352-z.